Fulgent Genetics: Q1 Earnings Insights

Fulgent Genetics FLGT reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Fulgent Genetics beat estimated earnings by 48.84%, reporting an EPS of $-0.22 versus an estimate of $-0.43.

Revenue was down $254.10 million from the same period last year.

Last quarter the company beat on EPS by $0.08 which was followed by a 2.87% drop in the share price the next day.

Here's a look at Fulgent Genetics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.56	0.05	0.73	3.86
EPS Actual	-0.48	0.32	0.78	5.08
Revenue Estimate	59.57M	91.36M	122.70M	270.85M
Revenue Actual	67.70M	105.66M	125.34M	320.27M

To track all earnings releases for Fulgent Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar